Gene: UBA5
Official Full Name: ubiquitin like modifier activating enzyme 5provided by HGNC
Gene Summary: This gene encodes a member of the E1-like ubiquitin-activating enzyme family. This protein activates ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein, via the formation of a high-energy thioester bond. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been identified on chromosome 1. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20561 | UBA5 Knockout cell line (HeLa) | Human | UBA5 | 1:3~1:6 | Negative | Online Inquiry |
KO20562 | UBA5 Knockout cell line (HCT 116) | Human | UBA5 | 1:2~1:4 | Negative | Online Inquiry |
KO20563 | UBA5 Knockout cell line (HEK293) | Human | UBA5 | 1:3~1:6 | Negative | Online Inquiry |
KO20564 | UBA5 Knockout cell line (A549) | Human | UBA5 | 1:3~1:4 | Negative | Online Inquiry |
UBA5 Gene Knockout Cell Lines are specialized in vitro systems designed to facilitate the study of the UBA5 gene's role in cellular processes. These cell lines are engineered using CRISPR/Cas9 technology to effectively delete the UBA5 gene, which encodes a critical E1 ubiquitin-activating enzyme involved in protein regulation and degradation pathways. This knockout enables researchers to investigate the consequences of UBA5 loss on various biological functions, including cellular stress responses, immune system modulation, and protein quality control mechanisms.
The key function of UBA5 in cellular homeostasis lies in its ability to activate ubiquitin and subsequently facilitate protein tagging for degradation via the proteasome pathway. By generating knockout cell lines, scientists can explore the downstream effects of UBA5 deficiency, assessing alterations in protein stability, signal transduction pathways, and overall cellular function. This deeper understanding can drive innovation in therapeutic development, particularly in diseases where protein dysregulation plays a pivotal role, such as cancer and neurodegenerative disorders.
One of the unique advantages of our UBA5 Gene Knockout Cell Lines is their reproducibility and reliability, as they are validated for consistent performance in various experimental settings. Unlike other gene manipulation methods that may yield off-target effects, our precise CRISPR technology ensures a clean gene knockout, allowing for accurate interpretation of experimental data.
Researchers and clinicians will find these cell lines invaluable for high-throughput screening applications, drug discovery, and fundamental biological research, as they offer a streamlined approach to studying gene function in a controlled environment.
Our commitment to excellence in biological research products is reflected in the rigorous development and validation of our UBA5 Gene Knockout Cell Lines, produced by our experienced team of scientists dedicated to advancing research in cellular biology. By choosing our product, users gain access to cutting-edge tools that enhance their research capabilities and yield impactful scientific insights.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.